These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2915 related items for PubMed ID: 9622837

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
    Just M, Berger R, Just V.
    Dev Biol Stand; 1986; 65():85-8. PubMed ID: 3030863
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Measles, mumps, rubella antibody surveillance: pilot study in Grampian, Scotland.
    Narayan KM, Moffat MA.
    Health Bull (Edinb); 1992 Jan; 50(1):47-53. PubMed ID: 1612895
    [Abstract] [Full Text] [Related]

  • 11. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH, Saracen CL, Peter G.
    Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [Abstract] [Full Text] [Related]

  • 12. Comparative evaluation of two combined measles-mumps-rubella vaccines based on AIK and Edmonston- Zagreb strains of measles virus.
    Mirchamsy H, Nilforoushan MA, Shafyi A, Razavi J, Ashtiani MP, Youssofi I, Sassani A, Fateh G, Nassiri S.
    Kitasato Arch Exp Med; 1991 Sep; 64(2-3):141-7. PubMed ID: 1811112
    [Abstract] [Full Text] [Related]

  • 13. The combination measles, mumps, rubella and varicella vaccine in healthy children.
    Arbeter AM, Baker L, Starr SE, Plotkin SA.
    Dev Biol Stand; 1986 Sep; 65():89-93. PubMed ID: 3030864
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of IgG-antibodies to mumps and measles virus in non-vaccinated children.
    Glikmann G, Petersen I, Mordhorst CH.
    Dan Med Bull; 1988 Apr; 35(2):185-7. PubMed ID: 3359817
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE, Kumar ML, Whitwell JK, Staehle BO, Rome LP, Dinakar C, Hurni W, Nalin DR.
    Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
    [Abstract] [Full Text] [Related]

  • 19. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine.
    André FE, Peetermans J.
    Dev Biol Stand; 1986 Aug; 65():101-7. PubMed ID: 3556770
    [Abstract] [Full Text] [Related]

  • 20. Humoral and cellular immune response after measles vaccination in Taiwan.
    Huang CL, Yang YH, Wang LC, Lin YT, Tsai YY, Chiang BL.
    J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 146.